Replies to post #50556 on Amarantus Bioscience Holdings Inc (AMBS)

[TradeSmart.ai]

But does it reduce the effects of Parkinson's? Does it stop it in its tracks? Or even possibly reverse it? Does it help with Alzheimer's and does it also prevent cell death in severe heart conditions? Concussions, does it give family members anymore reassurance as any test would with affirming the patient has the disease earlier? I think there is more to reducing the effects, stopping and or reversing the stages of these illnesses than there is to diagnosing them earlier.

AMBS is looking for a way to fund those things for MANF, the end game is still to get to that point, diagnosing illnesses earlier is just one of many ways they plan to get financing.

[zoomboom]

Nice Find, but it wont save money it is actually an add on test that will lead the patients to the NUROPRO Blood test for biomarkers. as it is stated in the column

There are many areas of medical practice and research where we think this could have an impact -- for example, reducing the need to visit the clinic to find out how the disease is progressing. We could do high-frequency monitoring for individualized treatment decisions. This might allow clinicians to optimize drug timing and dosage. For clinical trials, we could do cost-effective mass recruitment for new treatments. By recruiting very large numbers into trials we could help speed up the search for a cure. And finally, this could enable population-scale screening programs, that might allow us to search for 'biomarkers' that show early signs of the disease before the damage done is irreparable.[/quote]

[Caboomdoom]

In that case all. My friend they Parkinson's
And all my students